UNSPSC 85523746: Destruction of right axillary vein, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to destruction of right axillary vein, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 05573ZZ

UNSPSC 85523746 Destruction of right axillary vein, percutaneous approach (Commodity) does not align with recent state and local procurement activity. The code nominally describes a specific surgical procedure, yet the six most recent state and local opportunities tagged under it solicit medical evaluation services, health benefits administration, occupational surveillance, juvenile detention healthcare, pharmacy benefit management, and temporary health professional staffing—none of which involve vein destruction or percutaneous vascular procedures. The mismatch suggests either a taxonomy tagging error in the source data or a significant divergence between the code's clinical definition and how state and local procurement systems are currently applying it.

The recent opportunities show no procurement activity substantively related to the code's stated scope. The City of Phoenix Retirement Office solicited independent medical evaluation services for disability determinations; the City of Long Beach requested surgical benefit carve-out management for Centers of Excellence networks; the Washington State Department of Transportation sought occupational medical surveillance; Harris County Juvenile Probation issued an RFI for emergency and specialty care in detention; Collier County sought pharmacy benefit management; and Santa Clara County Health System established a temporary staffing pool for ancillary clinical roles. None involves the specific vascular procedure named in the code. Until state and local procurement offices tag relevant solicitations under 85523746, or until the code definition is reconciled with actual buying patterns, this code presents no actionable opportunity for vendors in the vascular procedure or related clinical domain.